Mera Pharmaceuticals Inc
OTC:MRPI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Mera Pharmaceuticals Inc
OTC:MRPI
|
US |
|
Nankai Plywood Co Ltd
TSE:7887
|
JP |
|
Q
|
Quipt Home Medical Corp
NASDAQ:QIPT
|
US |
|
A
|
Autohellas SA
ATHEX:OTOEL
|
GR |
|
P
|
PetroShale Inc
XTSX:PSH
|
CA |
|
Tomoe Corp
TSE:1921
|
JP |
|
A
|
Affinity Metals Corp
XBER:34IA
|
CA |
|
Trainline PLC
F:2T9A
|
UK |
|
U-SWIRL Inc
OTC:SWRL
|
US |
|
D
|
Durango Resources Inc
F:86A1
|
CA |
|
A
|
AI Technology Group Inc.
OTC:AIPG
|
US |
|
GSRX Industries Inc
OTC:GSRX
|
PR |
|
C
|
CIMB Thai Bank PCL
SET:CIMBT
|
TH |
|
M
|
Marie Brizard Wine and Spirits SA
SWB:BED
|
FR |
|
H
|
Hi Sharp Intelligence Technology Co Ltd
TPEX:3128
|
TW |
|
Valor Resources Ltd
ASX:THB
|
AU |
|
F
|
Fidia SpA
F:FIC0
|
IT |
|
A
|
ALBA SE
XBER:ABA
|
DE |
Bankruptcy Probability
Mera Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Mera Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Mera Pharmaceuticals Inc
OTC:MRPI
|
537 USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
451.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
233.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
180.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
137.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
54.8B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
82.5B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Mera Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Mera Pharmaceuticals Inc has total debt of 51.9k USD. This includes both short-term (51.9k USD) and long-term (0 USD) debt.
You can find a full breakdown on its Balance Sheet.
